About 14,400 results
Promising Early Phase Trial Results Lead to Orphan Drug โฆ
The FDA has granted Orphan Drug Designation (ODD) to NeoImmuneTech, Incโs efineptakin alfa (NT-17) for the treatment of pancreatic cancer. Efineptakin alfa is the only clinical stage long-acting human interleukin-7. 1. The ODD was based on early findings from an ongoing Phase I/II trial (NCT04332653) of the novel therapy in combination with ...FDA Grants Orphan Drug Designation for Acute Radiation โฆ
NeoImmuneTech bags orphan drug tag for IL-7 acute radiation โฆ
NodTheraโs NLRP3 Inhibitor NT-0796 Reverses Neuroinflammation โฆ
Native NMOS Blocked Implant (NT_N) | KNOW-HOW
What is NT-proBNP? What are normal levels and what do high โฆ
Territory Tourism Discount Scheme | Tourism Northern Territory